Beta-blockers have no impact on cocaine-related chest pain

June 3, 2014
β-blockers have no impact on cocaine-related chest pain

(HealthDay)—For patients with cocaine-associated chest pain, there are no differences in outcome for those treated with or without β-blockers, according to a study published in the June 1 issue of The American Journal of Cardiology.

Zaher Fanari, M.D., from the Christiana Care Health System in Newark, Del., and colleagues compared in-hospital outcomes for patients with cocaine-associated chest pain who were treated with and without β-blocker therapy. After adjustment for clinical characteristics, propensity scores were used to assess the independent correlation between β-blocker use and the composite primary end point of myocardial infarction, stroke, ventricular arrhythmia, or all-cause mortality.

The researchers found that β-blockers were used in 44 percent of the 376 patients with cocaine-related chest pain. Patients treated with β-blockers were more likely than those with no β-blockers to describe anginal chest pain, have known , and receive other antiatherosclerotic therapies. Patients treated with β-blockers experienced similar peak troponin levels, individual adverse events, and rates of the composite primary end point (15.9 versus 12.3 percent; P = 0.32), in spite of having higher risk clinical characteristics. After propensity score analysis, the primary end point was similar compared with patients not receiving β-blockers (odds ratio, 1.37; P = 0.42), including specific comparisons of beta-1 selective (odds ratio, 1.83; 95 percent confidence interval, 0.79 to 4.24) and nonselective (odds ratio, 0.90; 95 percent confidence interval, 0.33 to 2.42) β-blockers.

"No differences in outcomes were observed between treated versus not treated with β-blocker therapy in the setting of cocaine-related ," the authors write.

Explore further: Research suggests stroke risk up with beta-blockers in select patients

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Non-chest pain presentation doesn't worsen MI outcomes

December 30, 2014

(HealthDay)—Among patients with acute ST-elevation myocardial infarction (STEMI), presentation with non-chest pain delays door-to-balloon (DTB) time but does not worsen clinical outcomes, according to research published ...

Recommended for you

Optimism may reduce risk of dying prematurely among women

December 7, 2016

Having an optimistic outlook on life—a general expectation that good things will happen—may help people live longer, according to a new study from Harvard T.H. Chan School of Public Health. The study found that women ...

New discovery at heart of healthy cereals

December 6, 2016

A new discovery at the University of Queensland could help reduce heart disease and boost nutrition security – the access to balanced nourishment - globally.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.